Who
Andrew J. Murphy
Co-Chief Scientific Officer
Company insider
Files Form 4 as: Co-Chief Scientific Officer, Regeneron Pharmaceuticals.
In numbers
- Trades disclosed
- 313
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $60.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Dec 2019
- Last trade
- 14 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $42K55 at $762.57 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $19K25 at $763.76 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $167K219 at $764.40 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $207K271 at $765.39 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $214K279 at $766.47 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $147K192 at $767.39 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $81K105 at $768.33 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $98K127 at $769.30 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $9,24212 at $770.20 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $218K283 at $771.56 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $163K211 at $772.56 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $173K224 at $773.40 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $94K121 at $774.48 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $292K376 at $775.46 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $51K66 at $776.31 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $30K38 at $777.76 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $354K454 at $778.64 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $296K380 at $779.59 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $361K463 at $780.63 | filing |
| 14 Oct 2026filed 15 Oct 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $39K50 at $781.47 | filing |
News
1,598 Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Perpetual LtdREGN · dailypolitical.com · 15 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Up 3.6% – Here's What HappenedREGN · dailypolitical.com · 14 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $780.00REGN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Andrew J. Murphy; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.